Bob joined Elicio as CEO in October 2018. He is a prolific entrepreneur and company builder/leader with 30+ years of experience in the Life Sciences sector. Since 2000, Bob has been the CEO and/or Chairman of startup or early-stage novel therapeutic companies, including as the founding CEO and first employee of Domantis (sold to GSK in 2007 for $454 million, the largest all-cash purchase of a preclinical company at that date), CEO of Pulmatrix (NASDAQ:PULM) and CEO of Axcella Health (NASDAQ:ALXA).
Bob also served as a Venture Partner with Flagship Pioneering from 2013 to October 2018, working on the creation and management of 5 portfolio companies, including as a CEO of Axcella, Board member of Kaleido (NASDAQ:KLDO) and Kintai, Chairman of Aero Designs and Founding CEO of WikiCell Designs (Aero and Wiki merged into Incredible Foods in 2013). He raised over $300 million in financing and led many partnering transactions for his companies, including product and platform license, government and foundation funding and M&A transactions while launching many innovative platforms and products across disease areas.
Bob began his career with Abbott Laboratories, spending over 11 years in sales, sale-management, marketing and strategic marketing positions of increasing responsibility. He then spent 6 years with Bioveris (acquired by Roche for $1.6 billion) as SVP of Sales and Marketing and General Manager of the Life Sciences Business Unit, taking a lead marketing and investor communication roles in the company’s public financings of over $300 million.
Bob and his wife Marlen are both part of very large, thriving multi-ethnic families, spread all over the US, including three children of their own (all artists of different stripes). Despite growing up in South Florida, they’ve become true Bostonians over the last 20 years, spending any spare time soaking up everything the Boston area has to offer (including the best professional sports atmosphere IN THE WORLD).